A novel cost-effective assay based on real-time PCR for COMT Val158Met genotyping

Biomarkers. 2014 Nov;19(7):567-70. doi: 10.3109/1354750X.2014.948069. Epub 2014 Aug 6.

Abstract

A functional polymorphism in the catechol-O-methyltransferase (COMT) gene (Val158Met) has been associated with a large number of human diseases and endophenotypes. The aim of this study was to develop a novel cost-effective assay to genotype this polymorphism. The novel assay was based on the combination of allele-specific PCR and high-resolution melting in a qPCR platform. Melt-curve analysis allowed a clear differentiation of the three genotypes. This novel assay could be implemented in the study of a large number of diseases and endophenotypes related to COMT dysfunction and could be extended for the analysis of other functional polymorphisms.

Keywords: DNA genotyping; high-resolution melting; melt curve; real-time PCR; rs4680.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Catechol O-Methyltransferase / genetics*
  • Cost-Benefit Analysis*
  • Genetic Testing / economics*
  • Genetic Testing / methods
  • Genotype
  • Health Care Costs*
  • Humans
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Predictive Value of Tests
  • Real-Time Polymerase Chain Reaction / economics*
  • Reproducibility of Results

Substances

  • COMT protein, human
  • Catechol O-Methyltransferase